Hartland & Co. LLC decreased its position in shares of Aetna Inc (NYSE:AET) by 38.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,849 shares of the company’s stock after selling 1,178 shares during the quarter. Hartland & Co. LLC’s holdings in Aetna were worth $334,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in AET. Lloyds Banking Group plc bought a new position in Aetna during the 3rd quarter worth approximately $106,000. Moisand Fitzgerald Tamayo LLC bought a new position in Aetna during the 3rd quarter worth approximately $116,000. Cerebellum GP LLC bought a new position in Aetna during the 4th quarter worth approximately $125,000. Harel Insurance Investments & Financial Services Ltd. bought a new position in Aetna during the 4th quarter worth approximately $180,000. Finally, Signature Estate & Investment Advisors LLC bought a new position in Aetna during the 4th quarter worth approximately $182,000. 84.88% of the stock is currently owned by institutional investors and hedge funds.
Shares of Aetna Inc (AET) opened at $178.51 on Tuesday. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52. Aetna Inc has a fifty-two week low of $124.83 and a fifty-two week high of $194.40. The stock has a market cap of $58,362.50, a P/E ratio of 31.05, a PEG ratio of 1.45 and a beta of 0.60.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were issued a $0.50 dividend. The ex-dividend date was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.12%. Aetna’s dividend payout ratio (DPR) is presently 34.78%.
Several research firms recently weighed in on AET. Credit Suisse Group lifted their price objective on shares of Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 31st. Piper Jaffray Companies reissued a “buy” rating and set a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Cowen reissued a “buy” rating and set a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Citigroup lowered shares of Aetna from a “buy” rating to a “neutral” rating and lifted their price objective for the stock from $187.89 to $212.00 in a research note on Wednesday, January 31st. Finally, Deutsche Bank raised shares of Aetna from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $195.00 to $212.00 in a research note on Monday, January 22nd. Ten equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Aetna has an average rating of “Buy” and a consensus price target of $185.94.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.chaffeybreeze.com/2018/02/20/aetna-inc-aet-position-trimmed-by-hartland-co-llc.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.